Consistent with their mission to prioritize clinical convenience, practicality, and effectiveness, numerous considerations were incorporated into the design of their product lines. From the packaging, to the shape configurations, all relate to optimizing suitability for use and potential for clinical benefit. But, FIRST AND FOREMOST, its products were developed with design requirements for safety, and products provided for distribution are verified to satisfy these requirements.

What sets Seed Biotech apart is its process. They use precise methods to get measurable results and create better biologic products. Their proprietary decellularization process demonstrates a greater than 95% reduction in DNA.

Under the guidance of clinical and industry experienced experts, Seed Biotech’s core competency is based on a novel decellularization and stabilization process conducted in a quality by-design facility with advanced operational support systems.

Seed Biotech is uniquely able to optimally prepare highly variable biological materials through a dynamic purification process that depletes biomaterials of cells and cellular contents without imparting unintentional alterations to the extracellular matrix comprised of soluble and non-soluble bioactive constituents. This technology uniquely positions Seed Biotech as an industry leader in innovation and a manufacturer of high-quality products.